Amidst of COVID-19 outbreak, Infinium wishes to extend its support to the industry by offering 30% discount on its market research reports across all license formats.

Induced Pluripotent Stem Cells Market (Derived Cell Type - Fibroblasts, Amniotic Cells, Hepatocytes, Keratinocytes, and Others; Application - Drug Development, Regenerative Medicine, Toxicity Testing, and Academic Research; End User - Research Organizations, Hospitals, and Bio-pharma Industries): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : February, 2020

  • Rep Id : HC0814

  • Category : Healthcare & Medical Devices

  • Status : Published

A recent report published by Infinium Global Research on induced pluripotent stem cells market provides an in-depth analysis of segments and sub-segments in the global as well as regional induced pluripotent stem cells market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional induced pluripotent stem cells market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global induced pluripotent stem cells market. According to the report, the global induced pluripotent stem cells market is projected to grow at a CAGR of 8.6% over the forecast period of 2019-2025.

 

Segment Covered

The report on global induced pluripotent stem cells market covers segments such as derived cell type, application, and end user. On the basis of derived cell type, the sub-markets include fibroblasts, amniotic cells, hepatocytes, keratinocytes, and others. On the basis of application, the sub-markets include drug development, regenerative medicine, toxicity testing, and academic research. On the basis of end user, the sub-markets include research organizations, hospitals, and bio-pharma industries.

 

Companies Profiled:

The report provides profiles of the companies in the market such as Astellas Pharma Inc., Fate Therapeutics Inc, FUJIFILM Holdings Corporation, Evotec SE, Japan Tissue Engineering Co., Ltd, ViaCyte, Inc., Vericel Corporation, Bristol-Myers Squibb Company, Aastrom Biosciences, Inc., and Acelity Holdings, Inc.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of induced pluripotent stem cells market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount